You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UTHR Sale Disclosure
Rothblatt Martine A · SEC Form 4 · Filed Oct 2, 2026
Sale
Calculated transaction value
$185.29K
Rothblatt Martine A Chairperson & CEO
UTHR
Transaction date
Oct 1, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$571.38
Oct 1, 2026
First close after public filing
$536.4
Oct 5, 2026
30-day return after filing
+11.14%
Through Nov 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 320 shares @ $579.02
- SEC ownership
- Indirect
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001106578-26-000155
Filing cohort
Transactions in this filing
Showing 15 of 21
Trades
21
Issuers
1
Estimated value
$6.6M
Buys / sales
0 / 19
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $210.48K |
| United Therapeutics Corp UTHR | Exercise | Oct 1, 2026 | $1.12M |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $67.21K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $446.52K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $537.48K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $408.01K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $302.77K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $233.31K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $90.13K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $53.38K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $320.8K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $160.61K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $477.2K |
| United Therapeutics Corp UTHR | Sale | Oct 1, 2026 | $775.17K |
| United Therapeutics Corp UTHR Current | Sale | Oct 1, 2026 | $185.29K |